Login to Your Account



Zeltia Subsidiary Neuropharma Brings In EUR16M For Alzheimer's

By Cormac Sheridan


Wednesday, August 4, 2004
Neuropharma SA, a subsidiary of Zeltia Group, raised €16 million in its first external funding round to progress several preclinical programs in Alzheimer's disease. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription